| Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia? | |
| | |
MedLine Citation:
|
PMID: 21241006 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Blood transfusion during acute lymphoblastic leukemia (ALL) of childhood is scarcely documented. Children with ALL are immunosuppressed by both the disease and its therapy. Transfusion may contribute to the course of ALL through its transfusion-related immunomodulation (TRIM) effect. PROCEDURE: Blood transfusion history and response to therapy for 108 children <16 years of age at the time of ALL diagnosis was documented. Clinical files, electronic records, and blood bank registries were scrutinized. Overall survival (OS) and event-free survival (EFS) in relation to blood product type and number of transfusions was determined. Hazard ratios (HR) for death and relapse were estimated through uni- and multivariate Cox regression analysis. RESULTS: One hundred eight ALL patients were included. Median age was 6 years (range: 0-15 years). Ninety-seven patients (89.8%) were transfused. Median number of transfused products was seven (range: 0-345). After multivariate analysis, transfusion of >5 packed red blood cells (PRBC) remained a significant predictor for death (P = 0.003) and relapse (P = 0.011). For platelets, maximal significance was observed when >30 platelet concentrates (PC) were transfused (P < 0.001). When both, PRBC and PC were considered, maximal significance for predicting death was observed with transfusion of >30 blood products (P < 0.001). CONCLUSIONS: The number of blood products transfused to children with ALL appears to be significantly associated with lower survival rates. This may reflect both the severity of the disease and the TRIM effect, which may decrease immune surveillance capacity and the probability of leukemic clone eradication. Pediatr Blood Cancer © 2011 Wiley-Liss, Inc. |
| | |
Authors:
|
José Carlos Jaime-Pérez; Perla R Colunga-Pedraza; David Gómez-Almaguer |
Related Documents
:
|
7224116 - Nitrous oxide concentrations in the dental surgery, atmospheric and blood concentration... 18703366 - Stability of blood phenylalanine levels and iq in children with phenylketonuria. 23216456 - Modelling and simulation of blood collection systems: improvement of human resources al... 23264476 - Holding on to a shifting substrate: plasticity of egg mass tethers and tethering forces... 1672906 - In-vitro dissolution properties of indomethacin extended-release capsules. 21428676 - Multilaboratory particle image velocimetry analysis of the fda benchmark nozzle model t... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-1-16 |
Journal Detail:
|
Title: Pediatric blood & cancer Volume: - ISSN: 1545-5017 ISO Abbreviation: - Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-1-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101186624 Medline TA: Pediatr Blood Cancer Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Internal Medicine Division, Department of Hematology, "Dr. José Eleuterio González" University Hospital, School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Mexico. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Oral low-dose chemotherapy: Successful treatment of an alveolar rhabdomyosarcoma during pregnancy.
Next Document: Definitive radiotherapy for unresectable pediatric and young adult nonrhabdomyosarcoma soft tissue s...